My 2 top FTSE 100 starter stocks to buy and hold forever

These two great stocks could kick-start your portfolio as you invest for the long term.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I think an opportunity has opened up for investors in the shares of companies we like to describe as having ‘defensive’ businesses. The word ‘defensive’ doesn’t make them boring, far from it. These firms are among the most exciting and dynamic long-term holds you can buy on the London stock market. But because of their generally stable and predictable cash inflows, they also tend to be among the safest stocks to hold, hence the label ‘defensive.’

Improving valuations

Such attractions do not go unnoticed and over the past few years, many have piled into defensive stocks, while low interest rates rendered returns from bonds and bank accounts derisory. The thinking went something like this: “Bonds and bank accounts are rubbish, but look at those juicy dividends available from safe-looking defensive firms over there.” Strong buying pushed valuations of the defensives higher – perhaps too high.

Now, many investors seem to be rotating to cheaper-looking cyclical stocks. Defensive firms’ share prices are lower and valuations are starting to look attractive once more. I’ve been waiting for the downtrends in these stocks to falter for some time and think we are seeing evidence of basing now. So perhaps this is a good time to revisit the defensives with a long-term buy-and-hold strategy in mind. My top two FTSE 100 defensive starter stocks to buy and hold forever are both fast-moving consumer goods companies, Unilever (LSE: ULVR) and Reckitt Benckiser Group (LSE: RB).

Decent trading

In April with the first-quarter trading statement, Unilever chief executive Paul Polman said that trading for the year got off to a good start with good volume-driven performance across all three divisions.” He put this down to the firm’s ‘Connected 4 Growth’ programme, which aims to “enhance” the company’s “long-term compounding growth model.” 

Unilever expects underlying sales to grow between 3% and 5% for the full year and an improvement in underlying operating margin and cash flow, which suggests the company’s attention to cost-cutting and efficiency improvements is keeping growth on the agenda.

And in more good news for investors, the firm plans to buy back around €6bn of its own shares and also declared an 8% hike in the dividend “reflecting confidence in our outlook.” Growth looks as if it’s on track with Unilever and I see recent share-price weakness as an opportunity to buy the shares at a better valuation.

Reckitt Benckiser also recently reported a solid start to the year. Last year’s acquisition of Mead Johnson Nutrition Company prompted the firm to restructure into two divisions – RB Health and RB Hygiene Home. There’s some weakness in a few of the firm’s health brands, such as Scholl, but overall, the directors seem confident that organic growth will deliver revenues in line with expectations for the full year.

City analysts following the firm expect revenue to increase around 8% during 2018, which should deliver an uplift in earnings of around 3%. In 2019, they think earnings will rise 8%. Those earnings growth rates are a little lower than the double-digit advances we’ve seen in recent years. But the company has said: “We are addressing our performance in Scholl through acceleration of our pipeline, penetration improvement programmes and streamlining our range.” I think the stock is well worth your research time.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

£20,000 in an ISA? Here’s how I’d aim to make £1,250 a month in passive income

Our writer thinks one rare FTSE 100 stock could help drive an ISA portfolio higher, resulting in a sizeable passive…

Read more »

Black father holding daughter in a field of cows
Investing Articles

£25k of savings? Consider aiming for a £1k+ monthly passive income via this strategy

With a long-term mindset, investors could target a four-figure monthly passive income by investing £25k in low-volatility blue-chip stocks.

Read more »

Investing Articles

The Rolls-Royce share price hit new highs in November. What next?

November has been another record-breaking month for the Rolls-Royce share price. And the outlook for 2025 still looks bright.

Read more »

Investing Articles

Here’s the growth forecast for Sage Group shares to 2026!

Sage Group shares have rocketed following the tech firm's stunning third-quarter update. Is now the time to consider buying in?

Read more »

Investing Articles

10%+ dividend growth! 2 FTSE 250 shares tipped to turbocharge dividends

These FTSE 250 income shares look in great shape to grow their dividends by double-digit percentages, says our writer Royston…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

Would it be madness to buy this FTSE stock smashed by Donald Trump’s team picks?

Ben McPoland takes a look at one FTSE share inside his portfolio that has been battered lately due to a…

Read more »

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »